Predicted protein targets (top 1)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9330425 | 1.00 | LMNA (0.33) | LMNA | |
| SCHEMBL7895490 | 1.00 | LMNA (0.33) | LMNA | |
| SCHEMBL5008785 | 1.00 | LMNA (0.33) | LMNA | |
| SCHEMBL10712092 | 1.00 | LMNA (0.33) | LMNA | |
| SCHEMBL2133647 | 0.97 | — | — | |
| SCHEMBL30193671 | 0.93 | — | — | |
| SCHEMBL3464557 | 0.92 | — | — | |
| Ethylene Glycol SCHEMBL7771400 | 0.91 | — | — | |
| SCHEMBL332787 | 0.89 | — | — | |
| SCHEMBL3465412 | 0.89 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 197 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0345151-B2 | Method for production of hollow fiber membrane | TERUMO CORP (JP) | 2000-10-04 | — | — | EP | claimed |
| US-11987656-B2 | Method for producing fluorinated polymer and method for producing fluorinated ion exchange polymer | AGC Inc. (JP) | 2024-05-21 | — | — | US | disclosed |
| EP-3677570-B1 | FLUOROSULFONYL GROUP-CONTAINING COMPOUND, FLUOROSULFONYL GROUP-CONTAINING MONOMER, AND PRODUCTION METHODS FOR SAME | AGC INC (JP) | 2023-11-08 | — | — | EP | disclosed |
| CN-116874653-A | Electrolyte material, method for producing same, and use thereof | ＡＧＣ株式会社 | 2023-10-13 | — | — | CN | disclosed |
| US-20230307680-A1 | ELECTROLYTE MATERIAL, ITS PRODUCTION METHOD AND ITS USE | AGC Inc. (JP) | 2023-09-28 | — | — | US | disclosed |
| US-11767308-B2 | Method of stabilizing perfluorodioxolane compound, perfluorodioxolane compound-containing composition and method of producing perfluorodioxolane compound polymer | TOSOH CORPORATION (JP) | 2023-09-26 | — | — | US | disclosed |
| US-11746171-B2 | Method for fractionating liquid composition | AGC Inc. (JP) | 2023-09-05 | — | — | US | disclosed |
| CN-111527062-B | Fluorine-containing diene compound, fluorine-containing polymer, and method for producing same | ＡＧＣ株式会社 | 2023-07-21 | — | — | CN | disclosed |
| EP-3521325-B1 | POLYMER, POLYMER ELECTROLYTE MEMBRANE AND MEMBRANE/ELECTRODE ASSEMBLY | AGC INC (JP) | 2023-05-24 | — | — | EP | disclosed |
| EP-4183837-A1 | CHARGEABILITY IMPARTING AGENT, CHARGEABLE RESIN COMPOSITION AND CHARGED NONWOVEN FABRIC | Sanyo Chemical Industries, Ltd. (JP) | 2023-05-24 | — | — | EP | disclosed |
| US-20010018144-A1 | Block polymer, process for producing a polymer, and polymer electrolyte fuel cell | ASAHI GLASS COMPANY, LIMITED (JP) | 2001-08-30 | — | — | US | disclosed |
| EP-1126537-A1 | Block polymer, process for producing a polymer, and polymer electrolyte fuel cell | ASAHI GLASS COMPANY LTD. (JP) | 2001-08-22 | — | — | EP | disclosed |
| US-5639845-A | HYDROSILATION | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 1997-06-17 | — | — | US | disclosed |
| EP-0495823-B1 | EPOXIDATION OF FLUORINE CONTAINING OLEFINS | DU PONT (US) | 1994-04-13 | — | — | EP | disclosed |
| EP-0495823-A1 | EPOXIDATION OF FLUORINE CONTAINING OLEFINS. | DU PONT (US) | 1992-07-29 | — | — | EP | disclosed |
| US-5084583-A | Epoxidation of fluorine containing olefins | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 1992-01-28 | — | — | US | disclosed |
| WO-1991005778-A1 | EPOXIDATION OF FLUORINE CONTAINING OLEFINS | E.I. DU PONT DE NEMOURS AND COMPANY (US) | 1991-05-02 | — | — | WO | disclosed |
| EP-0138095-B1 | METHOD OF ALKOXYLATING FLUORINATED ALCOHOLS | E.I. DU PONT DE NEMOURS AND COMPANY (US) | 1988-07-27 | — | — | EP | disclosed |
| EP-0149347-B1 | PENTAHYDROPERFLUOROALKYLAMINE N-OXIDES | E.I. DU PONT DE NEMOURS AND COMPANY (US) | 1988-03-09 | — | — | EP | disclosed |
| EP-0149347-A1 | Pentahydroperfluoroalkylamine n-oxides | E.I. DU PONT DE NEMOURS AND COMPANY (US) | 1985-07-24 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11767308-B2 | Method of stabilizing perfluorodioxolane compound, perfluorodioxolane compound-containing composition and method of producing perfluorodioxolane compound polymer | PFAS, PFN1, PFKFB1 | LMNA 1499/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.